Skip to content

Price / sales at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
11.7×+5.0×
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
2.6×+0.8×
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
461.8×
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
149.5×-487×
Harmony Biosciences Holdings, Inc. logo
Harmony Biosciences Holdings, Inc.HRMY
1.8×-0.8×
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
22.9×+2.1×

Other financials

Income statement

See full
Revenue$6.2M-96.1%
Operating income-$53.4M-148%
Net income-$50.0M-144%
EPS (diluted)-$0.79-142%

Balance sheet

See full
Cash & equivalents$155.7M-43.4%
Total debt$3.4M-42.5%
Total equity$394.9M+12.8%
Total assets$443.3M+8.9%

Cash flow

See full
Operating cash flow-$60.6M-146%
CapEx$353.0K+132%
Free cash flow-$60.9M-146%

Valuation

See full
Market cap$1.94B+436%
Enterprise value$1.79B+1,855%

Profitability

See full
Operating margin-577.5%-597pp
Net margin-529.2%-556pp
FCF margin36.2%+18.4pp

Returns & leverage

See full
Return on equity-45.6%-66.1pp
Debt / equity0.0×
Current ratio+0.6×

Where this comes from

Calculated from Stoke Therapeutics, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stoke Therapeutics, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stoke Therapeutics, Inc.'s price / sales?
Stoke Therapeutics, Inc. (STOK) reported price / sales of 60× in Q1 2026.
How has Stoke Therapeutics, Inc.'s price / sales changed year-over-year?
Stoke Therapeutics, Inc.'s price / sales increased by 3087.1% year-over-year, from 1.9× to 60×.
What is the long-term trend for Stoke Therapeutics, Inc.'s price / sales?
Over 3 years (2022 to 2025), Stoke Therapeutics, Inc.'s price / sales has grown at a -30.5% compound annual growth rate (CAGR), from 29.3× to 9.8×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.